Role of non-macrophage cell-derived HMGB1 in oxaliplatin-induced peripheral neuropathy and its prevention by the thrombin/thrombomodulin system in rodents: negative impact of anticoagulants

Maho Tsubota(Kindai University), Atsufumi Kawabata(Kindai University)

Journal of Neuroinflammation

October 30, 2019

10.1186/s12974-019-1581-6

Cited by 45

Related Papers

<scp>AKAP</scp>‐dependent sensitization of<scp>Ca</scp><sub>v</sub>3.2 channels via the<scp>EP</scp><sub>4</sub>receptor/c<scp>AMP</scp>pathway mediates<scp>PGE</scp><sub>2</sub>‐induced mechanical hyperalgesia

|British Journal of Pharmacology|2012|37

Proteinase-Activated Receptor-2–Triggered Prostaglandin E2 Release, but Not Cyclooxygenase-2 Upregulation, Requires Activation of the Phosphatidylinositol 3–Kinase / Akt / Nuclear Factor-κB Pathway in Human Alveolar Epithelial Cells

|Journal of Pharmacological Sciences|2009|22

Caspase-Dependent HMGB1 Release from Macrophages Participates in Peripheral Neuropathy Caused by Bortezomib, a Proteasome-Inhibiting Chemotherapeutic Agent, in Mice

|Cells|2021|14